<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/location/san-diego/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/location/san-diego</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Thu, 09 Apr 2026 17:44:20 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries]]></title>
		<link>https://www.thaipr.net/en/health_en/3408895</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 14 Nov 2023 08:14:07 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3408895</guid>

					<description><![CDATA[<p>Program aims to address key barriers to genomic sequencing in-country Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs). The program, developed with guidance from [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3408895">Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[San Diego Zoo Safari Park Announces Elephant Valley, Largest Transformative Project in 50-year History]]></title>
		<link>https://www.thaipr.net/en/general_en/3368749</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Fri, 11 Aug 2023 08:00:00 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3368749</guid>

					<description><![CDATA[<p>Wildlife Conservation Leader Will Bring Guests Closer to Elephants Through New Immersive Experience  San Diego Zoo Wildlife Alliance has announced construction is officially underway on the largest and most transformative project in the San Diego Zoo Safari Park&#8217;s 50-year history. The all-new Denny Sanford Elephant Valley will reimagine the heart of the Safari Park, turning [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3368749">San Diego Zoo Safari Park Announces Elephant Valley, Largest Transformative Project in 50-year History</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
						<enclosure url="https://mma.prnewswire.com/media/2183084/San_Diego_Zoo_Wildlife_Alliance_PR.mp4" length="0" type="video/mp4" />
			</item>
		<item>
		<title><![CDATA[Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA]]></title>
		<link>https://www.thaipr.net/en/health_en/3361840</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Fri, 21 Jul 2023 17:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3361840</guid>

					<description><![CDATA[<p>Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to aid in the selection of patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML) who may be eligible to receive treatment with Daiichi Sankyo&#8217;s VANFLYTA® (quizartinib). The LeukoStrat CDx FLT3 Mutation Assay identifies FLT3-ITD positive AML patients who [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3361840">Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Invivoscribe Announces IVDR Approval of the LeukoStrat CDx FLT3 Mutation Assay]]></title>
		<link>https://www.thaipr.net/en/health_en/3335640</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 11 May 2023 17:05:22 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3335640</guid>

					<description><![CDATA[<p>&#8220;Today we are pleased to announce that Invivoscribe&#8217;s LeukoStrat® CDx FLT3 Mutation Assay has been approved by BSI (Netherlands) and the EMA as a Class C CDx assay, meeting the stringent new IVDR (Regulation (EU) 2017/746) requirements. Invivoscribe is one of the first companies in the world to gain an IVDR approval of a CDx assay. IVDR is [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3335640">Invivoscribe Announces IVDR Approval of the LeukoStrat CDx FLT3 Mutation Assay</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML]]></title>
		<link>https://www.thaipr.net/en/health_en/3255904</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 25 Oct 2022 09:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3255904</guid>

					<description><![CDATA[<p>Invivoscribe is pleased to announce that they have filed a supplemental Pre-Market Approval (sPMA) submission with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) for the use of the LeukoStrat® CDx FLT3 Mutation Assay as the companion diagnostic for Daiichi Sankyo&#8217;s investigational drug quizartinib. The assay is used for the identification of [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3255904">Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA]]></title>
		<link>https://www.thaipr.net/en/health_en/3219959</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 04 Aug 2022 08:23:30 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3219959</guid>

					<description><![CDATA[<p>Experiences of high blood pressure disorders during pregnancy are associated with an increased risk of vascular dementia and accelerated brain aging, according to studies reported today at the Alzheimer&#8217;s Association International Conference® (AAIC®) 2022 in San Diego and virtually. Hypertensive disorders of pregnancy (HDP) — conditions of high blood pressure including chronic/gestational hypertension and preeclampsia — have been [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3219959">HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[HIGHLIGHTS FROM THE ALZHEIMER&#8217;S ASSOCIATION INTERNATIONAL CONFERENCE 2022]]></title>
		<link>https://www.thaipr.net/en/health_en/3219958</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 04 Aug 2022 08:19:27 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3219958</guid>

					<description><![CDATA[<p>New research reported at the Alzheimer&#8217;s Association International Conference® (AAIC®) 2022 covered the breadth of Alzheimer&#8217;s and dementia research, including the basic biology of aging and the brain, risk factors and prevention strategies, and caregiving and living well with the disease. AAIC is the premier annual forum for presentation and discussion of the latest Alzheimer&#8217;s and dementia [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3219958">HIGHLIGHTS FROM THE ALZHEIMER&#8217;S ASSOCIATION INTERNATIONAL CONFERENCE 2022</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[LOWER SOCIOECONOMIC STATUS IN CHILDHOOD, PERSISTENT LOW WAGES LINKED TO RISK FOR DEMENTIA AND FASTER MEMORY DECLINE]]></title>
		<link>https://www.thaipr.net/en/health_en/3219400</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Wed, 03 Aug 2022 08:00:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3219400</guid>

					<description><![CDATA[<p>Socioeconomic deprivation, including neighborhood disadvantages and persistent low wages, are associated with higher dementia risk, lower cognitive performance and faster memory decline, according to several studies reported today at the Alzheimer&#8217;s Association International Conference® (AAIC®) 2022 in San Diego and virtually. Socioeconomic status (SES) — reflecting both social and economic measures of a person&#8217;s work experience, and of an individual&#8217;s [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3219400">LOWER SOCIOECONOMIC STATUS IN CHILDHOOD, PERSISTENT LOW WAGES LINKED TO RISK FOR DEMENTIA AND FASTER MEMORY DECLINE</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[EXPERIENCES OF RACISM ASSOCIATED WITH POOR MEMORY, INCREASED COGNITIVE DECLINE]]></title>
		<link>https://www.thaipr.net/en/health_en/3219789</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 02 Aug 2022 08:37:00 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3219789</guid>

					<description><![CDATA[<p>Experiences of structural, interpersonal and institutional racism are associated with lower memory scores and worse cognition in midlife and old age, especially among Black individuals, according to studies reported today at the Alzheimer&#8217;s Association International Conference® (AAIC®) 2022 in San Diego and virtually. Among the key findings reported at AAIC 2022 are: In a study of nearly 1,000 [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3219789">EXPERIENCES OF RACISM ASSOCIATED WITH POOR MEMORY, INCREASED COGNITIVE DECLINE</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS]]></title>
		<link>https://www.thaipr.net/en/health_en/3218210</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Mon, 01 Aug 2022 09:09:21 +0700</pubDate>
				<category>health_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/health_en/3218210</guid>

					<description><![CDATA[<p>FROM THE ALZHEIMER&#8217;S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Also, ICU Stay May Double Risk of Dementia in Older Adults  New insights into factors that may predict, increase or protect against the impact of COVID-19 and the pandemic on memory and thinking skills were revealed by multiple studies reported today at the Alzheimer&#8217;s Association International Conference® (AAIC®) 2022 in San [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/health_en/3218210">PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome]]></title>
		<link>https://www.thaipr.net/en/general_en/3205195</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Wed, 22 Jun 2022 17:00:00 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3205195</guid>

					<description><![CDATA[<p>New assay brings  validated HRD technology from Myriad Genetics to the Illumina TruSight™ Oncology 500, a single, comprehensive pan-cancer test to identify key variants critical for cancer development and progression Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of a research test, codeveloped with Merck (known as MSD outside [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3205195">Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
		<item>
		<title><![CDATA[Tealium Raises $96 Million in Series G Funding Led by Georgian and Silver Lake Waterman]]></title>
		<link>https://www.thaipr.net/en/it_en/3025461</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Thu, 04 Feb 2021 09:00:00 +0700</pubDate>
				<category>it_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/it_en/3025461</guid>

					<description><![CDATA[<p>Investment will fuel product innovation and expand global footprint to enhance service to enterprise customers. Tealium, the trusted leader in real-time customer data orchestration, today announced it raised $96 million in Series G funding led by existing investors Georgian and Silver Lake Waterman. The funding, which increases the company&#8217;s valuation to $1.2 billion, will be [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/it_en/3025461">Tealium Raises $96 Million in Series G Funding Led by Georgian and Silver Lake Waterman</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
